Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00702325 · ClinicalTrials.gov registry record · Phase 4
Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans
A Phase 4 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 4
- Development phase
- 311
- Enrollment target
NCT00702325: Completed Phase 4 study, sponsored by AstraZeneca.
NCT00702325 is a Phase 4 study that has completed, run by AstraZeneca. The registered enrollment target is 311 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00702325, a Phase 4 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 311 participants
- Enrollment target
Study Summary
To compare the efficacy of SYMBICORT® pMDI 160/4.5 μg x 2 actuations twice daily (bid) to that of budesonide inhalation powder DPI 180 μg x 2 inhalations bid, in African American(self-reported) subjects with inhaled corticosteroid (ICS) dependent asthma.
Primary Outcome
Mean change from baseline (Visit 3) value to average value recorded at visits during treatment period
Interventions
- DRUG Budesonide
- DRUG Budesonide / formoterol fumarate (SYMBICORT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 311 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-09 |
| Phase | Phase 4 |
What the finished NCT00702325 record still lists
NCT00702325 is an interventional study that assigns participants to a tested intervention. The registered 311 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (40% lower).
The record links to 0 conditions, and to 2 interventions - of which Budesonide is the first listed.
NCT00702325 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00702325 about?
NCT00702325 is a clinical study titled "Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans". To compare the efficacy of SYMBICORT® pMDI 160/4.5 μg x 2 actuations twice daily (bid) to that of budesonide inhalation powder DPI 180 μg x 2 inhalations bid, in African American(self-reported) subjects with inhaled corticosteroid (ICS) dependent asthma.
What is the current status of trial NCT00702325?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 311 participants. The study started on 2008-06. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00702325?
The interventions under investigation include: Budesonide (DRUG), Budesonide / formoterol fumarate (SYMBICORT) (DRUG).
Who is sponsoring clinical trial NCT00702325?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00702325's enrollment target sits among peer trials
311 263rd of 2000 higher than 1,738 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04984551 · 312 participants · Phase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- NCT04999904 · 312 participants · NA
A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability
- NCT05220332 · 312 participants · NA
Church-based Intervention to Improve Blood Pressure in African Americans
- NCT05434234 · 312 participants · Phase 1
A Study of YL201 in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia